Oramed Pharmaceuticals Inc.

Biotechnology • Healthcare • New York, NY, United States • ORMP (NCM)

Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions with a technology platform for the oral delivery of therapeutic proteins. It develops ORMD-0801, an oral insulin capsule, which is in phase III clinical trial for the treatment of individuals with diabetes. The company has license agreements with Oravax Medical Inc. to commercialize oral vaccines for COVID-19 and other novel coronaviruses. Oramed Pharmaceuticals Inc. was incorporated in 2002 and is headquartered in New York, New York.

844 967 2633 1185 Avenue of the Americas, New York, NY 10036, United States

Stock Performance (90 Days)

Data through Dec 30, 2025

Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

ORAMED PHARMACEUTICALS INC. DECLARES DIVIDEND DISTRIBUTION OF COMMON STOCK PURCHASE RIGHTS - PR Newswire

PR Newswire • Nov 17

Oramed Pharmaceuticals And 2 Other Promising Penny Stocks To Watch - Yahoo Finance

Yahoo Finance • Dec 16

Oramed Pharmaceuticals: Scarred, Well-Capitalized, And Regrouping After Setback - Seeking Alpha

Seeking Alpha • Dec 24

Oramed Pharmaceuticals completes $28.5 million warrant repurchase by Scilex - Investing.com

Investing.com • Dec 31

Oramed Reports Fiscal Third Quarter 2025 Financial Results - PR Newswire

PR Newswire • Nov 17

Other Biotechnology Companies

Vertex Pharmaceuticals Inc. / MA

$118.68B market cap

Regeneron Pharmaceuticals, Inc.

$82.72B market cap

Alnylam Pharmaceuticals, Inc.

Frequently Asked Questions

Has ORAMED PHARMACEUTICALS INC. had layoffs?

No layoff events have been recorded for ORAMED PHARMACEUTICALS INC. in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.

What industry is ORAMED PHARMACEUTICALS INC. in?

ORAMED PHARMACEUTICALS INC. operates in the Biotechnology industry, within the Healthcare sector.

Is ORAMED PHARMACEUTICALS INC. a publicly traded company?

Yes, ORAMED PHARMACEUTICALS INC. is publicly traded under the ticker symbol ORMP on the NCM. The company has a market capitalization of approximately $0.11 billion.

Where is ORAMED PHARMACEUTICALS INC. headquartered?

ORAMED PHARMACEUTICALS INC. is headquartered in New York, NY, United States at 1185 Avenue of the Americas, New York, NY 10036, United States.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.